111 related articles for article (PubMed ID: 29871820)
21. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
[TBL] [Abstract][Full Text] [Related]
23. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
24. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
[TBL] [Abstract][Full Text] [Related]
26. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
27. Correlation between HPV status at T and N sites of oropharyngeal squamous cell carcinomas.
Josiassen MV; Charabi B; Lajer CB; Garnaes E; Hamilton Therkildsen M; Norrild B; Specht L; Nielsen FC; von Buchwald C
Acta Otolaryngol; 2017 Dec; 137(12):1260-1264. PubMed ID: 28758552
[TBL] [Abstract][Full Text] [Related]
28. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.
Clark JM; Holmes EM; O'Connell DA; Harris J; Seikaly H; Biron VL
Papillomavirus Res; 2019 Jun; 7():1-10. PubMed ID: 30267774
[TBL] [Abstract][Full Text] [Related]
30. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
31. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
32. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
33. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
34. Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients.
Carpén T; Sjöblom A; Lundberg M; Haglund C; Markkola A; Syrjänen S; Tarkkanen J; Mäkitie A; Hagström J; Mattila P
Acta Otolaryngol; 2018 May; 138(5):513-518. PubMed ID: 29161981
[TBL] [Abstract][Full Text] [Related]
35. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
[TBL] [Abstract][Full Text] [Related]
36. Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer.
Mueller SK; Mantsopoulos K; Semrau S; Agaimy A; Eckstein M; Traxdorf M; Gostian AO; Goncalves M; Sievert M; Haderlein M; Grundtner P; Hecht M; Koch M; Fietkau R; Iro H; Scherl C
Acta Otolaryngol; 2021 Feb; 141(2):187-192. PubMed ID: 33108949
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
[TBL] [Abstract][Full Text] [Related]
38. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status.
Molony P; Kharytaniuk N; Boyle S; Woods RSR; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
Head Neck; 2017 Aug; 39(8):1680-1688. PubMed ID: 28560813
[TBL] [Abstract][Full Text] [Related]
39. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
Okami K
Int J Clin Oncol; 2016 Oct; 21(5):827-835. PubMed ID: 27380170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]